Composite Dental Bone Graft Substitute Market to Reach $2.61 Billion by 2035

The composite dental bone graft substitute market was valued at $1.35 billion in 2025 and is projected to reach $2.61 billion by 2035, registering a CAGR of 6.9% during the forecast period from 2026 to 2035. The market is being driven by the growing prevalence of severe oral diseases and tooth loss, which directly increases the need for dental implants and bone augmentation procedures. Severe periodontal disease and complete tooth loss remain significant global health challenges, particularly among older adults, creating sustained demand for regenerative solutions that restore bone volume and support implant stability. This health burden compels dental professionals to adopt advanced bone graft substitutes that enhance clinical outcomes in socket preservation, ridge augmentation, and implant site development, strengthening overall market expansion. The trend toward comprehensive oral rehabilitation, especially in aging societies, underscores the strategic importance of composite graft materials that combine favorable biological and handling properties. As dental care systems and clinicians respond to these clinical needs, the substitution of traditional approaches with advanced graft materials is reinforcing long?term market growth.

Browse the full report description of “Composite Dental Bone Graft Substitute Market Size, Share & Trends Analysis Report by Product Type (Ceramic-Collagen Composites, Allograft-Based Composites, Xenograft-Based Composites, and Synthetic-Polymer Composites), and by End-User (Dental Clinics, Hospitals, Ambulatory / Specialty Surgical Centers, and Academic / Research Institutions), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/composite-dental-bone-graft-substitute-market

According to the World Health Organization, nearly 7% of adults globally experience complete tooth loss, with prevalence rising to approximately 23% among those aged 60 years and above, underscoring a significant clinical demand for restorative dental procedures. In addition, around 1?billion people worldwide are affected by severe periodontal disease, a primary cause of alveolar bone loss that often requires grafting solutions before or during implant treatments. To meet these clinical needs, clinicians are increasingly adopting composite graft materials that offer both biological compatibility and predictable handling, enabling effective bone regeneration in complex anatomical scenarios. The growing global aging population further intensifies demand for preventive and restorative dental care, thereby expanding the use of bone graft substitutes in periodontal and implant procedures. Collectively, these factors are driving adoption and contributing to sustained growth within the composite dental bone graft substitute market.

Recent Strategic Developments Strengthening the Composite Dental Bone Graft Substitute Market

• In April 2024, Geistlich expanded its global regenerative dentistry portfolio by acquiring Brazilian medical technology company Bionnovation Biomedical. Active in over 20 countries, Bionnovation specializes in biomaterials for dental regeneration. The acquisition supports Geistlich's strategy to diversify through internal development, partnerships, and acquisitions while improving access to quality dental treatments in Latin America and other emerging markets.

• In July 2024, Dentsply Sirona enhanced its Symbios® Allograft line by introducing new mineralized and demineralized regenerative solutions for dental surgeries and implants. The updated portfolio features granule allografts, putty products, and the Symbios PerioDerm® acellular dermal matrix, designed to promote bone formation, volume, and stability for predictable long-term outcomes.

• In June 2024, Geistlich made a strategic investment in O.S.T Développement to strengthen its position in the allograft materials market. This investment enables global distribution of Allodyn® products, expanding Geistlich’s allograft offerings beyond the United States into Europe.

• In February 2024, RTI Surgical completed its acquisition of Cook Biotech, creating a regenerative medicine company with a comprehensive and differentiated portfolio of allograft and xenograft biomaterials. This move consolidates RTI Surgical’s presence in the global dental bone graft substitute market.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Product Type
  • End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – BioHorizons IPH, Inc., Dentsply Sirona Inc., Institut Straumann AG, Medtronic plc, Zimmer Biomet Holdings, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Composite Dental Bone Graft Substitute Market Report Segment

By Product Type

• Ceramic-Collagen Composites
• Allograft-Based Composites
• Xenograft-Based Composites
• Synthetic-Polymer Composites

By End-User

• Dental Clinics
• Hospitals
• Ambulatory / Specialty Surgical Centers
• Academic / Research Institutions

Global Composite Dental Bone Graft Substitute Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/composite-dental-bone-graft-substitute-market